Degenerative changes in the lumbar spine are usually not treatable with zoledronic acid.
Lumbar degenerative disease refers to the physiological pathological process of natural aging and degeneration of the lumbar spine, which is often manifested by osteophytes, ligament calcification, disc protrusion, bone deformity, etc. Zoledronic acid is a phosphate drug that can be used to inhibit the abnormal activity of osteoclasts and inhibit bone resorption. Zoledronic acid is a phosphate drug that can be used to inhibit the abnormal activity of osteoclasts and inhibit bone resorption, and is commonly used in the treatment of osteoporosis in postmenopausal women, but has no significant effect on lumbar spine degenerative lesions.
Zoledronic acid is a prescription drug and should be used in accordance with medical advice to avoid adverse reactions. After the lumbar degenerative changes, it is recommended that patients seek timely medical treatment, actively cooperate with the doctor’s diagnosis and treatment, and avoid blindly using medication to avoid delaying the condition.